Patents by Inventor Roger C. Adami

Roger C. Adami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240141342
    Abstract: A method for ameliorating or treating a malignant tumor by administering a therapeutically effective amount of a formulation containing RNAi agents. A formulation for use in distributing RNAi molecules targeted to a human GST-? for treating a malignant tumor in a subject. The formulation may include nanoparticles composed of an ionizable lipid, a DSPE lipid, and additional lipids. A drug product may be made by lyophilization of the formulation.
    Type: Application
    Filed: April 11, 2023
    Publication date: May 2, 2024
    Inventors: Bharat Majeti, Jean-Pierre Clamme, Li Wang, Roger C. Adami, Wenbin Ying
  • Patent number: 11708575
    Abstract: This invention provides formulations for use in distributing RNAi molecules targeted to a human GST-? for treating a malignant tumor in a subject. The formulation can include nanoparticles composed of an ionizable lipid, a DSPE lipid, and additional lipids. A drug product can be made by lyophilization of the formulation. This invention further provides methods for ameliorating or treating a malignant tumor by administering a therapeutically effective amount of a formulation containing the RNAi agents.
    Type: Grant
    Filed: November 15, 2019
    Date of Patent: July 25, 2023
    Assignee: Nitto Denko Corporation
    Inventors: Bharat Majeti, Jean-Pierre Clamme, Li Wang, Roger C. Adami, Wenbin Ying
  • Publication number: 20200157540
    Abstract: This invention provides formulations for use in distributing RNAi molecules targeted to a human GST-? for treating a malignant tumor in a subject. The formulation can include nanoparticles composed of an ionizable lipid, a DSPE lipid, and additional lipids. A drug product can be made by lyophilization of the formulation. This invention further provides methods for ameliorating or treating a malignant tumor by administering a therapeutically effective amount of a formulation containing the RNAi agents.
    Type: Application
    Filed: November 15, 2019
    Publication date: May 21, 2020
    Inventors: Bharat Majeti, Jean-Pierre Clamme, Li Wang, Roger C. Adami, Wenbin Ying
  • Publication number: 20180353607
    Abstract: This disclosure provides a range of amino acid lipid compounds and compositions useful for drug delivery, therapeutics, and the diagnosis and treatment of diseases and conditions. The amino acid lipid compounds and compositions can be used for delivery of various agents such as nucleic acid therapeutics to cells, tissues, organs, and subjects.
    Type: Application
    Filed: August 14, 2017
    Publication date: December 13, 2018
    Inventors: Steven C. Quay, Michael E. Houston, Jr., Pierrot Harvie, Roger C. Adami, Renata Fam, Mary Prieve, Kathy Fosnaugh, Shaguna Seth
  • Patent number: 9821067
    Abstract: Lipopeptide compounds having a central peptide HHHHHKHHHKKKHKHKKK (SEQ ID NO:15) and a lipophilic group attached to each terminus of the peptide, and salts thereof. The lipopeptides are useful for forming pharmaceutical compositions for delivery of nucleic acid agents, such as siRNA and mdRNA agents, as well as in methods for treating the signs and symptoms of disease.
    Type: Grant
    Filed: November 16, 2015
    Date of Patent: November 21, 2017
    Assignee: Marina Biotech, Inc.
    Inventors: Roger C. Adami, Michael E. Houston, Jr., Rachel E. Johns
  • Patent number: 9731016
    Abstract: This disclosure provides a range of tyrosine amino acid lipid compounds and compositions useful for drug delivery, therapeutics, and the diagnosis and treatment of diseases and conditions. The amino acid lipid compounds and compositions can be used for delivery of various agents such as nucleic acid therapeutics to cells, tissues, organs, and subjects.
    Type: Grant
    Filed: April 3, 2016
    Date of Patent: August 15, 2017
    Assignee: Marina Biotech, Inc.
    Inventors: Steven C. Quay, Michael E. Houston, Jr., Pierrot Harvie, Roger C. Adami, Renata Fam, Mary Prieve, Kathy Fosnaugh, Shaguna Seth
  • Publication number: 20170216227
    Abstract: Activity-generating delivery molecules comprising the structure R3—(C?O)-Xaa-NH—R4 wherein Xaa is any D- or L-amino acid residue with a non-hydrogen, substituted or unsubstituted side chain, R3—(C?O)— and —NH—R4 are independently a long chain group, each long chain group containing one or more carbon-carbon double bonds, and salts, compositions and methods of use thereof. The activity-generating delivery compounds and compositions are useful for generating activity of an active agent in a cell, tissue, or subject.
    Type: Application
    Filed: April 13, 2017
    Publication date: August 3, 2017
    Inventors: Renata Fam, Roger C. Adami, Kathy L. Fosnaugh, Pierrot Harvie, Rachel E. Johns, Shaguna Seth, Michael E. Houston, JR., Michael V. Templin
  • Publication number: 20160206739
    Abstract: This disclosure provides a range of tyrosine amino acid lipid compounds and compositions useful for drug delivery, therapeutics, and the diagnosis and treatment of diseases and conditions. The amino acid lipid compounds and compositions can be used for delivery of various agents such as nucleic acid therapeutics to cells, tissues, organs, and subjects.
    Type: Application
    Filed: April 3, 2016
    Publication date: July 21, 2016
    Inventors: Steven C. Quay, Michael E. Houston, JR., Pierrot Harvie, Roger C. Adami, Renata Fam, Mary Prieve, Kathy Fosnaugh, Shaguna Seth
  • Patent number: 9339461
    Abstract: This disclosure provides a range of amino acid lipid compounds and compositions useful for drug delivery, therapeutics, and the diagnosis and treatment of diseases and conditions. The amino acid lipid compounds and compositions can be used for delivery of various agents such as nucleic acid therapeutics to cells, tissues, organs, and subjects.
    Type: Grant
    Filed: September 25, 2014
    Date of Patent: May 17, 2016
    Assignee: Marina Biotech, Inc.
    Inventors: Steven C. Quay, Michael E. Houston, Jr., Pierrot Harvie, Roger C. Adami, Renata Fam, Mary G. Prieve, Kathy L. Fosnaugh, Shaguna Seth
  • Publication number: 20160058870
    Abstract: Lipopeptide compounds having a central peptide and a lipophilic group attached to at least one terminus of the peptide, or to at least one amino acid residue of the peptide, and salts and uses thereof. The lipophilic group may be attached to the N-terminus, C-terminus or both termini of the peptide. The lipophilic group may be attached to at least one interal amino acid residue. The lipophilic group may be attached to either termini or both and at least one internal amino acid residue.
    Type: Application
    Filed: November 16, 2015
    Publication date: March 3, 2016
    Inventors: Roger C. Adami, Michael E. Houston, JR., Rachel E. Johns
  • Patent number: 9220785
    Abstract: Lipopeptide compounds with a central peptide and having lipophilic groups attached at each terminus, and salts and uses thereof. The lipophilic groups can be derived from a naturally-occurring lipid, or can be a C(1-22)alkyl, C(6-12)cycloalkyl, C(6-12)cycloalkyl-alkyl, C(3-18)alkenyl, C(3-18)alkynyl, C(1-5)alkoxy-C(1-5)alkyl, or a sphinganine, or (2R,3R)-2-amino-1,3-octadecanediol, icosasphinganine, sphingosine, phytosphingosine, cis-4-sphingenine. The compounds can be used in compositions to deliver active agents to cells, including interfering-RNA agents and antisense RNAs.
    Type: Grant
    Filed: December 14, 2012
    Date of Patent: December 29, 2015
    Assignee: Marina Biotech, Inc.
    Inventors: Roger C. Adami, Michael E. Houston, Jr., Rachel E. Johns
  • Publication number: 20150209283
    Abstract: Processes and compositions for liposomal delivery of therapeuticals prepared by contacting an aqueous solution of an active agent with a solution of liposome-forming components containing one or more DILA2 amino acid compounds or lipids in organic solvent to form an impinging stream. A protocol including flow rates, pH, and an incubation period are used to control formation of liposomal components for therapeutic applications. The impinging stream may be collected and incubated to prepare a liposomal formulation which encapsulates the active agent. The composition can be quenched with buffer and filtered by tangential flow and diafiltration and other means for finishing as a pharmaceutical composition.
    Type: Application
    Filed: April 9, 2015
    Publication date: July 30, 2015
    Inventors: Barry A. Polisky, Roger C. Adami, Michael V. Templin, Pierrot Harvie, Rachel E. Johns, Jaya S. Giyanani, Michael E. Houston, JR.
  • Publication number: 20150073038
    Abstract: Activity-generating delivery molecules comprising the structure R3—(C?O)-Xaa-NH—R4 wherein Xaa is any D- or L-amino acid residue with a non-hydrogen, substituted or unsubstituted side chain, R3—(C?O)— and —NH—R4 are independently a long chain group, each long chain group containing one or more carbon-carbon double bonds, and salts, compositions and methods of use thereof. The activity-generating delivery compounds and compositions are useful for generating activity of an active agent in a cell, tissue, or subject.
    Type: Application
    Filed: November 16, 2014
    Publication date: March 12, 2015
    Inventors: Renata Fam, Roger C. Adami, Kathy L. Fosnaugh, Pierrot Harvie, Rachel E. Johns, Shaguna Seth, Michael E. Houston, JR., Michael V. Templin
  • Publication number: 20150017233
    Abstract: This disclosure provides a range of amino acid lipid compounds and compositions useful for drug delivery, therapeutics, and the diagnosis and treatment of diseases and conditions. The amino acid lipid compounds and compositions can be used for delivery of various agents such as nucleic acid therapeutics to cells, tissues, organs, and subjects.
    Type: Application
    Filed: September 25, 2014
    Publication date: January 15, 2015
    Inventors: Steven C. Quay, Michael E. Houston, JR., Pierrot Harvie, Roger C. Adami, Renata Fam, Mary G. Prieve, Kathy L. Fosnaugh, Shaguna Seth
  • Patent number: 8877729
    Abstract: This disclosure provides a range of amino acid lipid compounds and compositions useful for drug delivery, therapeutics, and the diagnosis and treatment of diseases and conditions. The amino acid lipid compounds and compositions can be used for delivery of various agents such as nucleic acid therapeutics to cells, tissues, organs, and subjects.
    Type: Grant
    Filed: July 1, 2013
    Date of Patent: November 4, 2014
    Assignee: Marina Biotech, Inc.
    Inventors: Steven C. Quay, Michael E. Houston, Jr., Pierrot Harvie, Roger C. Adami, Renata Fam, Mary G. Prieve, Kathy L. Fosnaugh, Shaguna Seth
  • Publication number: 20140037714
    Abstract: This disclosure provides a range of amino acid lipid compounds and compositions useful for drug delivery, therapeutics, and the diagnosis and treatment of diseases and conditions. The amino acid lipid compounds and compositions can be used for delivery of various agents such as nucleic acid therapeutics to cells, tissues, organs, and subjects.
    Type: Application
    Filed: July 1, 2013
    Publication date: February 6, 2014
    Applicant: Marina Biotech, Inc.
    Inventors: Steven C. Quay, Michael E. Houston, Jr., Pierrot Harvie, Roger C. Adami, Renata Fam, Mary G. Prieve, Kathy L. Fosnaugh, Shaguna Seth
  • Publication number: 20140019151
    Abstract: Methods, devices and systems for performing personalized wellness healthcare by forming a patient personal assessment using one or more bioindicator levels and one or more personal indicator communications. A processor assigns relational impact factors to the input, and a differentiator determines a diagnosis or prognosis based on normal and disease states. A treatment and/or wellness plan can be generated. The methods, devices and systems can be operated in a kiosk, and/or remotely.
    Type: Application
    Filed: June 28, 2013
    Publication date: January 16, 2014
    Applicant: Permesys, Inc.
    Inventors: Roger C. Adami, David P. Bowler
  • Publication number: 20130231382
    Abstract: Lipopeptide compounds comprising a peptide having 2 to 100 amino acid residues, and having a lipophilic group attached to at least one terminus of the peptide or to at least one amino acid residue of the peptide, and salts and uses thereof. The lipophilic group may be attached to the N-terminus, C-terminus or both termini of the peptide. The lipophilic group may be attached to at least one interal amino acid residue (i.e., an amino acid residue that is not the N-terminus or the C-terminus amino acid residue of the peptide). The lipophilic group may be attached to either termini or both and at least one internal amino acid residue.
    Type: Application
    Filed: December 14, 2012
    Publication date: September 5, 2013
    Applicant: MARINA BIOTECH, INC.
    Inventors: Roger C. Adami, Michael E. Houston, JR., Rachel E. Johns
  • Patent number: 8501824
    Abstract: This disclosure provides a range of amino acid lipid compounds and compositions useful for drug delivery, therapeutics, and the diagnosis and treatment of diseases and conditions. The amino acid lipid compounds and compositions can be used for delivery of various agents such as nucleic acid therapeutics to cells, tissues, organs, and subjects.
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: August 6, 2013
    Assignee: Marina Biotech, Inc.
    Inventors: Steven C. Quay, Michael E. Houston, Jr., Pierrot Harvie, Roger C. Adami, Renata Fam, Mary G. Prieve, Kathy L. Fosnaugh, Shaguna Seth
  • Publication number: 20130072424
    Abstract: Compounds comprising condensed particles having diameters less than 1000 nm, wherein the particles comprise one or more double stranded ribonucleic acids (dsRNAs) and one or more peptides. The compounds, compositions and methods are useful for modulating gene expression by RNA interference.
    Type: Application
    Filed: May 18, 2012
    Publication date: March 21, 2013
    Applicant: MARINA BIOTECH, INC.
    Inventors: Roger C. Adami, Tianying Zhu, Kunyuan Cui, Michael E. Houston, JR., Lishan Chen, Yuching Chen